Akoustis Technologies, Inc.
Akoustis Technologies, Inc., through its subsidiary, Akoustis, Inc., designs, develops, manufactures, and sells radio frequency (RF) filter products for the wireless industry in the Americas, Asia, Europe, and internationally. It operates in two segments, Fabrication Services and RF Filters. The Fabrication Services segment provides engineering review and backend packaging services. The RF Filter… Read more
Akoustis Technologies, Inc. (AKTSQ) - Total Liabilities
Latest total liabilities as of September 2024: $122.59 Million USD
Based on the latest financial reports, Akoustis Technologies, Inc. (AKTSQ) has total liabilities worth $122.59 Million USD as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Akoustis Technologies, Inc. - Total Liabilities Trend (2021–2024)
This chart illustrates how Akoustis Technologies, Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Akoustis Technologies, Inc. Competitors by Total Liabilities
The table below lists competitors of Akoustis Technologies, Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
High Mountain 2 Capital Corporation
V:HMCC-P
|
Canada | CA$1.31K |
|
Royce Global Value Trust Inc
NYSE:RGT
|
USA | $432.94K |
|
CHUBU EL - Dusseldorf Stock Exchang
DU:0C2
|
Germany | €4.41 Trillion |
|
Orbite Technologies Inc
PINK:EORBF
|
USA | $47.01 Million |
|
BURBERRY GROUP
BE:BB2
|
Germany | €2.22 Billion |
|
PZU (7PZ.SG)
STU:7PZ
|
Germany | €424.08 Billion |
|
Medivie Therapeutic Ltd
TA:MDVI
|
Israel | ILA9.13 Million |
|
CELLAVISION
BE:C26
|
Germany | €215.97 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down Akoustis Technologies, Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.88 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2.14 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Akoustis Technologies, Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Akoustis Technologies, Inc. (2021–2024)
The table below shows the annual total liabilities of Akoustis Technologies, Inc. from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-06-30 | $126.83 Million | +102.36% |
| 2023-06-30 | $62.68 Million | +8.24% |
| 2022-06-30 | $57.91 Million | +663.55% |
| 2021-06-30 | $7.58 Million | -- |